New study: Topical Pain Relief Market Forecast to 2025

Global Topical Pain Relief Industry was valued at USD 8.248 Million in the year 2018. Global Topical Pain Relief Industry is further estimated to grow at a CAGR of 7.34% from 2019 to reach USD 13,468 Million by the year 2025. North America region holds the highest Industry share and Asia Pacific is considered as the fastest growing Industry in the forecasted period. At the country level, U.S, China and Japan are considered to be the fastest growing Industry in the coming years owning to high disposable income and growing healthcare industry.

The global topical pain relief Industry is segmented based on therapeutic class, type, formulation, distribution channel, and region. On the basis of therapeutic class, the Industry is segmented into non-opioids and opioids, of these opioids segment accounts for the largest Industry share and is projected to grow at a moderate CAGR of XX%.

By type, the topical pain relief Industry is segmented into prescription pain relief and over-the-counter (OTC) relief. Over-the-counter pain relief segment accounted for the largest Industry share in 2018 due to easy availability and high demand of topical pain relief products by sportsperson. By distribution channel, the Industry is segmented into pharmacies & drug stores, e-commerce, and retail & grocery stores.

Request Sample Copy of this Market Research Report @ https://www.alexareports.com/report-sample/9423

Major market players in Topical Pain Relief Industry are GlaxoSmithKline plc., Johnson & Johnson, Pfizer Inc., AdvaCare Pharma, Novartis AG, Nestlé S.A., Sanofi, Sun Pharmaceutical Industries Ltd., Topical BioMedics, Inc., Reckitt Benckiser Group plc, and Other 9 more companies information is provided in the report.

SWOT analysis of Topical Pain Relief Industry

Strength:

Growing prevalence of arthritis and bone related health problems

Growing old age population

Weakness:

Various side effects associated by using pain relief products

Opportunities:

Growing demand in sports and athletic players

Growing awareness of online pharmacy

Threats:

Availability of alternative pain management therapies

Topical Pain Relief Industry Segmentation:

Topical Pain Relief Industry Overview, By Therapeutic Class

• Non-Opioids

o Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)

o Methyl Salicylate

o Capsaicin

o Lidocaine

o Other Non-opioids

• Opioids

o Buprenorphine

o Fentanyl

Topical Pain Relief Industry Overview, By Type

• Prescription Pain Relief

• Over-the-counter (OTC) Pain Relief

Topical Pain Relief Industry Overview, By Formulation

• Cream

• Gel

• Spray

• Patch

• Others

Topical Pain Relief Industry Overview, By Distribution Channel

• Pharmacies & Drug Stores

• E-Commerce

• Retail & Grocery Stores

Inquiry before Buying @

https://www.alexareports.com/send-an-enquiry/9423

Table of Content

1. Introduction

1.1 Industry Vision

1.2 Limitations

1.3 Stakeholders

3. Executive Summary

4. Industry Overview

4.1. Introduction

4.2. Strength

4.3. Weakness

4.4. Opportunities

4.5. Threats

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Threat of Substitutes

5.2.3. Bargaining Power of Buyers

5.2.4. Bargaining Power of Suppliers

5.2.5. Intensity of Competitive Rivalry

6. Topical Pain Relief Industry, By Therapeutic Class

6.1 Non-Opioids

6.1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)

6.1.2 Methyl Salicylate

6.1.3 Capsaicin

6.1.4 Lidocaine

6.1.5 Other Non-opioids

6.2 Opioids

6.2.1 Buprenorphine

6.2.2 Fentanyl

7. Topical Pain Relief Industry, By Type

7.1 Prescription Pain Relief

7.2 Over-the-counter (OTC) Pain Relief

8. Topical Pain Relief Industry, By Formulation

8.1 Cream

8.2 Gel

8.3 Spray

8.4 Patch

8.5 Others

9. Topical Pain Relief Industry, By Distribution Channel

9.1 Pharmacies & Drug Stores

9.2 E-Commerce

9.3 Retail & Grocery Stores

Buy Now @

https://www.alexareports.com/checkout/9423